Arecor Therapeutics plc (AIM:AREC)
London · Delayed Price · Currency is GBP · Price in GBX 63.13
-0.38 (-0.59%)
Jul 24, 2026, 10:57 AM GMT
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 23.98 million as of July 24, 2026. Its market cap has increased by 22.12% in one year.
Market Cap
23.98M
Enterprise Value
17.94M
Revenue
1.71M
Ranking
n/a
PE Ratio
31.75
Stock Price
63.13
ChartMarket Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 23.98M, a decrease of -64.21%. That is a compound annual growth rate of -18.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 23.98M | -21.12% |
| Dec 31, 2025 | 30.39M | 9.52% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
| Jun 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Poolbeg Pharma | 46.57M |
| hVIVO | 46.37M |
| Hemogenyx Pharmaceuticals | 45.97M |
| Sareum Holdings | 32.56M |
| SkinBioTherapeutics | 31.75M |
| ImmuPharma | 26.20M |
| IXICO | 18.53M |
| Aptamer Group | 16.41M |